“High-Cost Drugs”

65 result(s)
Drug Pipeline
New migraine drugs are closer to approval and expanding treatment choices for many patients More
Briefing
Cost Management
2022 CVS Caremark Formulary Updates Deliver Exceptional Value and Cost Management More
Briefing
Cost Management
CVS Health offers strategies for addressing new-to-market products to ensure access to clinically appropriate insulin or other medications. More
Commentary
Drug Pipeline
Biosimilars help to increase market competition. Balancing the use of biosimilars and biologics with strategic formulary decisions deliver lower costs. More
Briefing
Cost Management
As part of the CVS Health hyperinflation strategy, our Outlier Pharmacy Program proactively monitors and identifies pharmacies with increased volume in claims submissions of... More
Briefing
Drug Pipeline
Projected Approvals of Pipeline Gene Therapies Expected to Treat Conditions with Few Options More
Briefing
Cost Management
Our job at CVS Caremark is to be the best manager of our clients’ pharmacy spend, which includes better engaging patients and their providers throughout the duration of therapy,... More
Feature
Pipeline Therapies Could Expand Choices for Conditions with Limited Options | Payor Solutions | CVS Health
Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Cost Management
Changes to CVS Caremark template formularies effective January 1, 2021 continue our legacy of innovation as well as delivering value and quality care — helping clients save money... More
Briefing